Antiretroviral Therapy
HAART changes hepatitis B and C viremia in patients coinfected with HIV
Published in AIDS Weekly, November 8th, 2004
"Chronic infection with either hepatitis B (HBV) or hepatitis C virus (HCV) is frequently present in patients seropositive for human immunodeficiency virus (HIV) because of shared routes of transmission," according to investigators in the United States.
"With the advent of highly active antiretroviral therapy (HAART) regimens capable of controlling HIV replication and dramatically prolonging the survival of HIV-infected patients, the impact of co-morbid infections such as HBV and HCV has come into focus. Several studies have monitored HBV or HCV viral loads following initiation...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-11-08)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Cobas Amplicor HIV Monitor 1.5 test modified to measure proviral DNA in PBMCs - HIV/AIDS Drug Resistance
Primary drug resistance persists in recently HIV-1 infected adults - HIV/AIDS Therapy
Imperatorin inhibits HIV-1 replication through Sp1-dependent pathway - Obstetrics
Co-infection with HIV and malaria in pregnant women remains a challenge - AIDS/HIV Epidemiology
Temporal trends in HIV-1 epidemic in Russia reported - AIDS/HIV Vaccine
HDAC inhibitors reactivate HIV-1 expression in cellular reservoirs - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
